10 hakuartikkelia 2023 vuodelta Covidin aiheuttamasta keuhkoödemasta . Delta -variantti ollut pahin aiheuttaja.

 

Lung Injury in COVID-19 Has Pulmonary Edema as an Important Component and Treatment with Furosemide and Negative Fluid Balance (NEGBAL) Decreases Mortality.

Santos JLF, Zanardi P, Alo V, Dos Santos V, Bovone L, Rodriguez M, Magdaleno F, De Langhe V, Villoldo A, Martinez Souvielle R, Alconcher J, Quiros D, Milicchio C, Garcia Saiz E. J Clin Med. 2023 Feb 15;12(4):1542. doi: 10.3390/jcm12041542. PMID: 36836076 Free PMC article.

The result is excessive retention of water, producing a state of noxious hypervolemia. Consequently, in COVID-19 injury lung is pulmonary edema. Our report is a case-control study, retrospective. We included 116 patients with moderate-severe …

2

Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant.

Jeican II, Inișca P, Gheban D, Anton V, Lazăr M, Vică ML, Mironescu D, Rebeleanu C, Crivii CB, Aluaș M, Albu S, Siserman CV. J Pers Med. 2023 Jan 31;13(2):279. doi: 10.3390/jpm13020279. PMID: 36836513 Free PMC article.

BACKGROUND: The Delta variant (Pango lineage B.1.617.2) is one of the most significant and aggressive variants of SARS-CoV-2. To the best of our knowledge, this is the first paper specifically studying pulmonary morphopathology in COVID- …

3

Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema.

Zubieta-Calleja GR, Zubieta-DeUrioste N, de Jesús Montelongo F, Sanchez MGR, Campoverdi AF, Rocco PRM, Battaglini D, Ball L, Pelosi P. Respir Physiol Neurobiol. 2023 Mar;309:104000. doi: 10.1016/j.resp.2022.104000. Epub 2022 Nov 29. PMID: 36460252 Free PMC article. Review.

Coronavirus disease-2019 (COVID-19) may severely affect respiratory function and evolve to life-threatening hypoxia. The clinical experience led to the implementation of standardized protocols assuming similarity to severe acute …

4

Extracorporeal Membrane Oxygenation in Children With COVID-19: A Systematic Review and Meta-Analysis.

Watanabe A, Yasuhara J, Karube T, Watanabe K, Shirasu T, Takagi H, Sumitomo N, Lee S, Kuno T. Pediatr Crit Care Med. 2023 May 1;24(5):406-416. doi: 10.1097/PCC.0000000000003113. Epub 2022 Nov 17. PMID: 36516348 Free PMC article.

The most common indications for ECMO were multisystem inflammatory syndrome in children (52% [47/90]) and severe acute respiratory distress syndrome (40% [36/90]). ...CONCLUSIONS: The mortality of children on ECMO for COVID-19 was …

5

Atypical negative pressure pulmonary edema after extracorporeal membrane oxygenation therapy for COVID-19.

Suzuki Y, Ogoshi T, Taura Y, Oda S, Uchiyama D, Ueda H, Yatera K. Respirol Case Rep. 2022 Dec 8;11(1):e01071. doi: 10.1002/rcr2.1071. eCollection 2023 Jan. PMID: 36514343 Free PMC article.

However, in our case, NPPE showed a peripheral accent pattern, resembling the ARDS pattern of COVID-19 pneumonia 4 months ago. Capillary damage from COVID-19 might still exist....

6

Upper Airway Complications in COVID-19: A Case Series.

Shrestha S, Shin Y, Sostin OV, Pinkhasova P, Chronakos J. Cureus. 2023 Apr 5;15(4):e37163. doi: 10.7759/cureus.37163. eCollection 2023 Apr. PMID: 37153305 Free PMC article.

Prolonged intubations were particularly common during the initial phase of the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to present a series of five cases of upper airway complications in patients who underwent mechanical ventilati …

7

Montelukast as a potential treatment for COVID-19.

McCarthy MW. Expert Opin Pharmacother. 2023 Apr;24(5):551-555. doi: 10.1080/14656566.2023.2192866. Epub 2023 Mar 19. PMID: 36927284 Review.

AREAS COVERED: Montelukast has also been noted to have anti-inflammatory properties, suggesting it may have a role in the treatment of coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome …

8

Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.

Fu Y, Xue H, Wang T, Ding Y, Cui Y, Nie H. Biomed Pharmacother. 2023 Jul;163:114863. doi: 10.1016/j.biopha.2023.114863. Epub 2023 May 9. PMID: 37172333 Free PMC article. Review.

Lifeways of worldwide people have changed dramatically amid the coronavirus disease 2019 (COVID-19) pandemic, and public health is at stake currently. In the early stage of severe acute respiratory syndrome coronavirus …

9

Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.

Mohd Zawawi Z, Kalyanasundram J, Mohd Zain R, Thayan R, Basri DF, Yap WB. Int J Mol Sci. 2023 Mar 24;24(7):6142. doi: 10.3390/ijms24076142. PMID: 37047115 Free PMC article. Review.

Several previous studies revealed the impact of the imbalanced innate immune response on the progression of COVID-19 and its disease outcomes. High levels of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukins are produced read …

10

Inter-rater reliability and prognostic value of baseline Radiographic Assessment of Lung Edema (RALE) scores in observational cohort studies of inpatients with COVID-19.

Al-Yousif N, Komanduri S, Qurashi H, Korzhuk A, Lawal HO, Abourizk N, Schaefer C, Mitchell KJ, Dietz CM, Hughes EK, Brandt CS, Fitzgerald GM, Joyce R, Chaudhry AS, Kotok D, Rivera JD, Kim AI, Shettigar S, Lavina A, Girard CE, Gillenwater SR, Hadeh A, Bain W, Shah FA, Bittner M, Lu M, Prendergast N, Evankovich J, Golubykh K, Ramesh N, Jacobs JJ, Kessinger C, Methe B, Lee JS, Morris A, McVerry BJ, Kitsios GD. BMJ Open. 2023 Jan 12;13(1):e066626. doi: 10.1136/bmjopen-2022-066626. PMID: 36635036 Free PMC article.

OBJECTIVES: To reliably quantify the radiographic severity of COVID-19 pneumonia with the Radiographic Assessment of Lung Edema (RALE) score on clinical chest X-rays among inpatients and examine the prognostic value of baseline RALE scores on COVID- …